Hirudin Plus Aspirin in the Secondary Prevention of Cardioembolic Stroke Due to Nonvalvular Atrial Fibrillation
Status:
Completed
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
To investigate the efficacy and safety of hirudin plus aspirin therapy compared with warfarin
in the secondary prevention of cardioembolic stroke due to nonvalvular atrial fibrillation.
Details
Lead Sponsor:
Xijing Hospital
Collaborators:
451 Hospital Ankang Central Hospital Baoji Central Hospital Baoji People's Hospital Central Hospital of China Railway 20th Bureau First Affiliated Hospital Xi'an Jiaotong University Hanzhong Central Hospital Shaanxi people's Hospital Shaanxi Provincial People's Hospital Shangluo Central Hospital Shangluo Second People's Hospital Tang-Du Hospital The Third Hospital of PLA Xi'an Central Hospital Xi'an Ninth Hospital Xiangyang Central Hospital Xianyang 215 hospital Yan'an people's Hospital Yan'an University Affiliated Hospital Yulin Second Hospital